Estimation of serum and urinary profibrotic cytokines in renal allograft recipients
Medical Journal of Cairo University [The]. 2003; 71 (Supp. 2): 119-127
em Inglês
| IMEMR
| ID: emr-63813
ABSTRACT
In this study, serum and urinary transforming growth factor beta 1 [TGF- beta 1] and platelet derived growth factor [PDGF] levels were determined by enzyme-linked immunosorbent assay [ELISA] in ten renal allograft recipients for more than one year with normal renal function [group I], ten renal allograft recipients for more than one year with impaired renal function [group II] and ten patients with chronic renal failure [CRF] under conservative therapy [group III] and the measurements were compared with the levels of ten healthy controls [group IV]. The data confirmed the crucial contribution of the profibrotic cytokines TGF-beta 1 and PDGF in the development of chronic graft dysfunction that could be further augmented by cyclosporine A therapy. Further studies are needed to examine the effect of manipulation of immunosuppressive regimen on the extent of profibrotic gene expression as well as the long-term graft survival
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Transplante Homólogo
/
Fator de Crescimento Derivado de Plaquetas
/
Citocinas
/
Fator de Crescimento Transformador beta
/
Ciclosporina
/
Sobrevivência de Enxerto
/
Testes de Função Renal
/
Testes de Função Hepática
Tipo de estudo:
Ensaio Clínico Controlado
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Med. J. Cairo Univ.
Ano de publicação:
2003
Similares
MEDLINE
...
LILACS
LIS